tiprankstipranks
Coherus BioSciences options imply 21.5% move in share price post-earnings
PremiumThe FlyCoherus BioSciences options imply 21.5% move in share price post-earnings
1M ago
Options Volatility and Implied Earnings Moves Today, March 13, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 13, 2024
1M ago
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
PremiumPress Releases
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
1M ago
Coherus Biosciences Appoints New Director, Boosts Governance
PremiumCompany AnnouncementsCoherus Biosciences Appoints New Director, Boosts Governance
2M ago
Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
PremiumPress Releases
Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
2M ago
Coherus Biosciences announces U.S. launch of UDENYCA ONBODY
PremiumThe Fly
Coherus Biosciences announces U.S. launch of UDENYCA ONBODY
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Coherus Biosciences price target lowered to $8 from $12 at Truist
PremiumThe Fly
Coherus Biosciences price target lowered to $8 from $12 at Truist
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100